SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

48,888.32 -274.62
(-0.56%)

Dow Jones

7,157.73 -2.07
(-0.03%)

Hang Seng

59,153.23 -764.23
(-1.28%)

Nikkei 225

10,371.76 158.65
(1.55%)

Forex

USD-INR

94.52 0.35
(0.37%)

EUR-INR

110.65 0.18
(0.17%)

GBP-INR

127.71 0.18
(0.14%)

JPY-INR

0.59 0.00
(0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

NESCO Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

505355

INE317F01035

397.2116919

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NESCO

21.1

8615.14

EPS(TTM)

Face Value()

Div & Yield %

57.96

0.53

Back

yaari digital integrated services ltd

Concord Biotech consolidated net profit declines 33.59% in the September 2025 quarter

Nov 15,2025

Net profit of Concord Biotech declined 33.59% to Rs 63.58 crore in the quarter ended September 2025 as against Rs 95.74 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	247.06	310.18	-20
OPM %	35.82	43.11	-
PBDT	104.08	143.65	-28
PBT	85.68	130.34	-34
NP	63.58	95.74	-34

76,913.50 -582.86 ( -0.75%)

48,888.32 -274.62 (-0.56%)

7,157.73 -2.07 (-0.03%)

59,153.23 -764.23 (-1.28%)

10,371.76 158.65 (1.55%)

94.52 0.35 (0.37%)

110.65 0.18 (0.17%)

127.71 0.18 (0.14%)

0.59 0.00 (0.25%)